SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Bitcoins selloff amid concerns over a reported Binance security breach is weighing on Strategy shares, with traders debating whether the crypto-market shock signals deeper trouble or a buying opportunity. Concerns about Strategys quarterly results and CFO transition add to the bearish discussion, while some investors expect a rebound.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

DaVitas warning that DefenCaths Medicare add-on reimbursement could decline sharply after the first quarter of 2027 has fueled concern about pricing and CorMedixs largest revenue driver, alongside a steep selloff. Traders disagree on whether the comments signal a lasting revenue threat or are preliminary, DaVita-specific estimates with limited visibility into future reimbursement and utilization.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TGTX has reached fresh 52-week highs, with traders focused on an expected Q3 earnings report and debating whether the rally reflects BRIUMVI growth expectations or speculative buyout hopes and short covering. The buyout talk remains unconfirmed, and the earnings date has not been officially confirmed.

Whirlpool Corp. engages in the manufacturing and marketing of home appliances. Its products include home laundry appliances, refrigerators and freezers, cooking appliances, home dishwashers, and room air-conditioning equipment, mixers, and portable household appliances. The firm's brands include Whirlpool, KitchenAid, Maytag, Consul, Brastemp, Amana, Bauknecht, JennAir, and Indesit. It operates through the following geographical segments: Major Domestic Appliances (MDA) North America, Major Domestic Appliances (MDA) Latin America, Small Domestic Appliances (SDA) Global, and Others. The company was founded by Emory Upton, Fred Upton, and Louis C. Upton on November 11, 1911 and is headquartered in Benton Harbor, MI.

Whirlpool Corp.

Whirlpools weak Q1 results, sharply reduced full-year outlook and dividend suspension have driven attention, as the company cited recession-level appliance demand and blamed the Iran war and collapsing consumer confidence. Many traders are alarmed by the worsening outlook and debt burden, while some see the selloff as an overreaction and are buying for a possible rebound.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Weaker 2027 Medicare Advantage star ratings for Aetna are driving concern about lost bonus payments and future margin pressure. Traders are comparing CVSs weakness with Humanas rally on improved ratings, while debating whether the setback is already priced in.

Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody. The company was founded by Richard A. Miller, Peter A. Thompson, Joseph J. Buggy, and Erik Verner on January 27, 2014 and is headquartered in South San Francisco, CA.

Corvus Pharmaceuticals Inc

Traders are focused on a possible update on Corvuss ALPS program around the ASH abstract release and a company call, though the timing and whether the data will be disclosed remain uncertain. Optimism about a potential catalyst is countered by concerns over past delays, managements limited updates and heavy short interest.

Revolution Medicines, Inc. is a clinical-stage precision oncology company, which engages in developing novel targeted therapies. It engages in the discovery and development of cancer treatment by pioneering novel combination and monotherapy treatment regimens to maximize the depth and durability of clinical benefit and circumvent adaptive resistance mechanisms for patients which are dependent on the RAS and mTOR pathway. The company was founded by Mark A. Goldsmith, Kevan Shokat, Martin D. Burke, David L. Pompliano and Michael Fischbach in October 2014 and is headquartered in Redwood City, CA.

Revolution Medicines Inc

RASONQUE (daraxonrasib), Revolution Medicines pancreatic cancer therapy, remains the main focus: traders cite its Phase 3 survival results and FDA approval as support for the companys commercial and broader RAS-drug pipeline prospects. Discussion is also divided over valuation and efficacy across KRAS subtypes, with some traders pointing to competition from selective G12D drugs such as Verastems VS-7375.

Iovance Biotherapeutics, Inc. engages in the development and commercialization of cell therapies using autologous tumor-infiltrating lymphocytes (TIL) for the treatment of cancer. Its products include Amtagvi (lifileucel), and Proleukin (aldesleukin). The firm also develops investigational TIL therapies for other solid tumor cancers. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovances updated NSCLC trial results and shift toward biomarker-selected lung-cancer studies are driving attention: the overall response rate was 24.6%, while a retrospective subgroup showed a stronger signal, but the lung-cancer filing is expected in 2027 and durability remains uncertain. Traders are divided between viewing the selloff as an overreaction to promising precision-treatment data and seeing a narrower, delayed opportunity compounded by managements confusing presentation.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apples fiscal fourth-quarter earnings report is the focus, with traders debating whether its premium valuation can be justified amid memory-cost pressures and concerns about iPhone demand and upgrade cycles. Some expect a sharp post-report drop, while others view Apples restrained AI spending and relative resilience during the tech selloff as supporting its safe-haven appeal.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowheads interim ARO-MAPT resultsshowing substantial tau reduction and supporting subcutaneous delivery of RNAi to the central nervous systemare a major focus. Traders broadly view the data as encouraging platform validation, but many are frustrated that the share price has not reflected the positive results and debate whether the weakness is market-driven or a sell-the-news reaction.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CBOE Q3 Earnings Beat Estimates on Strong Options Volumes

Cboe Global's Q3 earnings surge 36% as record options activity and Data Vantage revenue growth drive results and lift its 2026 outlook.

Intercontinental Q3 Earnings Beat on Exchanges and Data Growth

Intercontinental Exchange beats Q3 earnings estimates as trading and data grow, with higher recurring revenue forecasts and a faster MarketAxess deal timeline.

IntercontinentalExchange (ICE) Tops Q3 Earnings and Revenue Estimates

ICE (ICE) delivered earnings and revenue surprises of +2.54% and +1.33%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Here's What Key Metrics Tell Us About ICE (ICE) Q3 Earnings

Although the revenue and EPS for ICE (ICE) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Intercontinental Exchange Approves Fourth Quarter Dividend of $0.52 per Share

Intercontinental Exchange (NYSE: ICE), one of the worlds leading providers of financial market technology and data powering global capital markets, announced today a $0.52 per share dividend for the fourth quarter of 2026, which is up 8% from the $0.48 per share dividend paid in the fourth quarter...

Intercontinental Exchange Q3 26 Earnings Conference Call At 8:30 AM ET

(RTTNews) - Intercontinental Exchange Inc. (ICE) will host a conference call at 8:30 AM ET on October 29, 2026, to discuss Q3 26 earnings results...

Intercontinental Exchange  Inc. Reveals Rise In Q3 Profit

(RTTNews) - Intercontinental Exchange Inc. (ICE) reported earnings for its third quarter that Increases, from the same period last year...

Intercontinental Exchange Reports Third Quarter 2026

Intercontinental Exchange (NYSE: ICE): 3Q26 net revenues of $2.8 billion, +15% y/y 3Q26 GAAP diluted earnings per share (EPS) of $1.67, +18% y/y 3Q26 adj. diluted EPS of $2.02, +18% y/y 3Q26 operating income of $1.4 billion, +20% y/y; adj. operating income of $1.7 billion, +19% y/y 3Q26 operating...

Intercontinental Exchange and Trade[XYZ] to Bring Hyperliquid-Based Perpetual Markets Onshore

Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, and Trade[XYZ], a leading deployer of real-world-asset perpetual futures markets on Hyperliquid, today announced a definitive agreement to bring...

ICE First Look: September Delinquencies Track Seasonal Norms as Foreclosure Pipeline Shifts Toward Recent Vintages

Intercontinental Exchange, Inc. (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets, today released the September 2026 ICE First Look at mortgage delinquency, foreclosure and prepayment trends. Key takeaways from this months...

$ICE Q3 &#39;26 Earnings Results &amp; Recap

• Reported GAAP EPS of $2.02 up 18.13% YoY
• Reported revenue of $3.63B up 20.72% YoY
• Intercontinental Exchange expects 2026 exchange and fixed income and data services recurring revenue growth of 9% and 8%, respectively; 4Q26 operating expenses are $1.32B GAAP and $1.08B non-GAAP.

Stocktwits

Intercontinental Exchange Inc

 Q3 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.02 up 18.13% YoY
• Reported revenue of $3.63B up 20.72% YoY
• Intercontinental Exchange expects 2026 exchange and fixed income and data services recurring revenue growth of 9% and 8%, respectively; 4Q26 operating expenses are $1.32B GAAP and $1.08B non-GAAP.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Intercontinental Exchange, Inc. engages in the provision of market infrastructure, data services and technology solutions. It operates through the following segments: Exchanges, Fixed Income and Data Services, and Mortgage Technology. The Exchanges segment operates marketplace technology for the listing, trading, and clearing of derivatives contracts and financial securities, as well as data and connectivity services. The Fixed Income and Data Services segment provides fixed income pricing, reference data, indices, analytics, and execution services as well as global credit default swap, or CDS, clearing, and multi-asset class data delivery technology. The Mortgage Technology segment provides a technology platform that offers digital workflow tools to address inefficiencies and mitigate risks that exist in the US residential mortgage market lifecycle from application through closing, servicing, and the secondary market. The company was founded by Jeffrey C. Sprecher in 2000 and is headquartered in Atlanta, GA.

SEC Targets Blockchain Era With Transfer Agent Rule Overhaul As Wall Street Ramps Up Tokenization

Cryptocurrency

Bullish Sentiment

<ul class="summary-bullets"><li>SEC Chair Paul Atkins said the changes would better match how transfer agents operate today, including the use of blockchain technology.</li><li>The proposal could give tokenized securities a clearer framework for recording ownership and transferring shares on distributed ledgers.</li><li>Tokenization is accelerating on Wall Street and across the financial industry as a whole.&nbsp;</li></ul>The U.S. Securities and Exchange Commission (SEC) on Tuesday proposed a sweeping change to rules covering registered transfer agents, the companies that keep track of who owns securities and move securities between investors, in an effort to update the rules.Transfer agents are regulated financial intermediaries that maintain shareholder records, facilitate the transfer of securities, and manage certain corporate actions.The proposed changes, the SEC said, would modernize a regulatory framework that has not changed much in decades and could make the rules better suited for modern securities markets and emerging technologies.SEC Chairman Paul Atkins&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/SECPaulSAtkins/status/2094815903527366973">said</a>, “This proposal would streamline and modernize the Commission’s rules to reflect transfer agents’ current processes and operations, including the use of electronic communications and blockchain technology in connection with securities offerings and the transfer of shares.”<figure class="image"><a class="st-link-external" href="https://x.com/SECPaulSAtkins/status/2094815903527366973" target="_blank" rel="noopener noreferrer nofollow"><img src="https://news.stocktwits-cdn.com/Screenshot_2026_09_01_at_1_09_28_PM_8b7438d232.png" alt="Screenshot 2026-09-01 at 1.09.28 PM.png" width="796" height="302"></a><figcaption>Source: @SECPaulSAtkins/x</figcaption></figure>The proposal also has implications for the booming market in tokenized securities and blockchain-based financial infrastructure, as companies increasingly explore distributed ledger technology to record and transfer ownership.<h2 class="st-heading-2">Why It Matters</h2>The&nbsp;proposal is a big deal because it aims to update rules written mostly for a paper-and-early-electronic age to reflect today’s digital financial markets, including the increasing use of electronic recordkeeping and blockchain technology. The proposal could also impact tokenized securities, potentially helping to create a clearer regulatory framework for recording and transferring ownership on distributed ledger systems.&nbsp;<h2 class="st-heading-2">Wall Street’s Tokenization Boom</h2>Tokenization is accelerating on Wall Street and across the financial industry as a whole. Exchanges, asset managers, and crypto platforms are increasingly looking into blockchain-based versions of stocks, funds, and other traditional assets. The New York Stock Exchange and Securitize (SECZ) are working together on a platform for tokenized securities.On Monday, tZERO and Intercontinental Exchange (ICE) agreed to work together on infrastructure for tokenized securities. tZERO will help build the digital transfer agent and broker-dealer systems for ICE's planned tokenized securities platform that is linked to the New York Stock Exchange (NYSE).&nbsp;It could also help set standards for digital transfer agents as more public stocks move to blockchain-based infrastructure, the company said.<a href="https://stocktwits.com/symbol/ICE">ICE’s stock</a> was down over 1% in midday trade. On Stocktwits, retail sentiment around ICE remained in the ‘bearish’ zone, accompanied by ‘high’ chatter levels over the past day.Read also:&nbsp;<a href="https://stocktwits.com/news-articles/markets/cryptocurrency/ark-glassnode-rank-bitcoin-most-decentralized-ethereum-solana-face-different-trade-offs/cZsooLHRJMi">ARK, Glassnode Rank Bitcoin Most Decentralized – Ethereum, Solana Face Different Trade-Offs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

U.S. Securities and Exchange Commission Chairman Paul S. Atkins poses for pohotos before ringing the closing bell at the Nasdaq Marketsite on December 02, 2025 in New York City. (Photo by Michael M. Santiago/Getty Images)

The SEC proposed updating decades-old transfer agent rules to reflect electronic communications and blockchain-based securities systems.

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$168.85
Prev Close	$163.04
Open	$166.68
Dividend Yield	1.19%
50-Day Moving Average	$157.57
Beta	0.42
Avg. Volume	3.05M
PE Ratio	23.04

52-Week High	$176.05
52-Week Low	$121.79
Market Capitalization	$94.36B
EPS (Annual)	$5.77
Price to Book	3.15
Revenue Per Employee	$952,039.86

Feed

News

Sentiment

Earnings

Fundamentals

Info

ICE Fundamentals